Evofem Biosciences
Edit

Evofem Biosciences

http://www.evofem.com/
Last activity: 06.09.2022
Tags:BioTechCommerceHealthTechProduct
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company's first commercial product, Phexxi®, is the first and only hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The Company’s lead product candidate, EVO100, is being evaluated for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women in the ongoing Phase 3 clinical trial, ‘EVOGUARD.’
Mentions
49
Location: United States, California, San Diego
Employees: 51-200
Total raised: $160M
Founded date: 2009
Twitter
Facebook
Instagram
LinkedIn
Email

Investors 2

Funding Rounds 5

DateSeriesAmountInvestorsDeal News
12.10.2021Series B$10M-marketscre...
17.05.2021-$50M-marketscre...
15.10.2020-$25M-prnewswire...
11.06.2019-$50M-socaltech....
04.08.2016-$25M-socaltech....

Mentions in press and media 49

DateTitleDescriptionSource
06.09.2022She's A CEO, Not A Female CEOSaundra Pelletier, Chief Executive Officer, President, and Executive Director of Evofem Biosciences ...forbes.com...
11.07.2022Evofem’s Wild RideEvofem's Phexxi is a hormone-free contraceptive for women. Image courtesy of Evofem Biosciences The ...sdbj.com/n...
28.06.2022Birth-control drugmaker Evofem Biosciences has spiked 240% s...Evofem Biosciences shares spiked 240% in the past two days following the overturning of Roe vs. Wade...businessin...
20.04.2022Women Raising Capital: How I Worked Around Obstacles And Rai...Saundra Pelletier, Chief Executive Officer, President, and Executive Director of Evofem Biosciences ...forbes.com...
09.02.2022FDA Awards QIDP Designation for Prevention of Chlamydia to E...SAN DIEGO, Feb. 9, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) announced today tha...marketscre...
19.01.2022Evofem Biosciences Announces Record Net Sales and Phexxi Pre...SAN DIEGO, Jan. 19, 2022 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced str...marketscre...
12.01.2022Phexxi Access to Expand under New Government Guidance Statin...SAN DIEGO, Jan. 12, 2022 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today commended the...marketscre...
16.12.2021Evofem Biosciences and Orion Biotechnology Launch Collaborat...SAN DIEGO, Dec. 16, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) and Orion Biotechno...marketscre...
09.12.2021Evofem Biosciences Expects Record High Phexxi Prescriptions ...SAN DIEGO, Dec. 9, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced bull...marketscre...
22.11.2021Evofem Biosciences Successfully Extends Cumulative Net Sales...SAN DIEGO, Nov. 22, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced th...marketscre...
Show more